| Sandoz Pharmaceuticals AG - Afqlir 40 mg/ml, Injektionslösung | | 70127 | | 01 | | Afqlir 40 mg/ml | | Injektionslösung | | S01LA05 | | Aflibercept | | 25.09.2025 | | |
| | Composition | | afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.05 ml corresp. natrium 1.73 µg. | | Packungsbestandteile | | Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Afliberceptum | 2mg / 0.05ml |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Histidin Hydrochloride Monohydrate | | Histidine | | Sodium Hydroxide | | Polysorbatum 20 | | Trehalosum Dihydricum |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | | | B | | Non |
|
|
